Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

Y Fang, W Liu, Z Tang, X Ji, Y Zhou, S Song, M Tian… - Hepatology, 2023 - journals.lww.com
Monocarboxylate transporter 4 inhibition potentiates hepatoc... : Hepatology
Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma …

Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

Y Fang, W Liu, Z Tang, X Ji, Y Zhou… - Hepatology …, 2023 - pubmed.ncbi.nlm.nih.gov
Background and aims Monocarboxylate transporter (MCT) 4 is a high-affinity lactate
transporter that is primarily involved in the maintenance of intracellular pH homeostasis and …

Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

Y Fang, W Liu, Z Tang, X Ji, Y Zhou, S Song… - …, 2023 - ingentaconnect.com
Background and Aims: Monocarboxylate transporter (MCT) 4 is a high‐affinity lactate
transporter that is primarily involved in the maintenance of intracellular pH homeostasis and …

Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack.

Y Fang, W Liu, Z Tang, X Ji, Y Zhou, S Song… - Hepatology …, 2022 - europepmc.org
Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma
immunotherapy through enhancing T cell infiltration and immune attack. - Abstract - Europe …

Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

Y Fang, W Liu, Z Tang, X Ji, Y Zhou, S Song, M Tian… - Hepatology - Wiley Online Library
Abstract Background and Aims Monocarboxylate transporter (MCT) 4 is a high‐affinity
lactate transporter that is primarily involved in the maintenance of intracellular pH …